GM Advisory Group’s GSK GSK Stock Holding History

GM Advisory Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$217K	Buy	+3,933	New	+$213K	0.01%	343
2025 Q3	–	Sell	-5,431	Closed	-$209K	–	309
2025 Q2	$209K	Buy	5,431 +64	+1%	+$2.45K	0.01%	274
2025 Q1	$208K	Sell	5,367 -2,668	-33%	-$97.7K	0.01%	253
2024 Q4	$272K	Buy	8,035 +1,300	+19%	+$46.8K	0.02%	219
2024 Q3	$275K	Hold	6,735	–	–	0.02%	210
2024 Q2	$259K	Hold	6,735	–	–	0.02%	200
2024 Q1	$289K	Hold	6,735	–	–	0.02%	184
2023 Q4	$250K	Buy	6,735 +200	+3%	+$7.18K	0.02%	180
2023 Q3	$237K	Hold	6,535	–	–	0.02%	173
2023 Q2	$233K	Buy	+6,535	New	+$234K	0.02%	175

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

GM Advisory Group's GSK Position: Q1 2026 in Review

GM Advisory Group opened a new position in GSK (GSK) in Q1 2026: 3,933 shares worth $217K. The stake represents 0.01% of the portfolio and ranks #343 among its holdings. This is a return to the name: GM Advisory Group previously reported a position in GSK as recently as Q2 2025.

GM Advisory Group first reported a position in GSK in Q2 2023 and has held it in 10 quarters since. The position peaked at $289K in Q1 2024. 1,035 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

GM Advisory Group held 3,933 shares of GSK worth $217K as of Q1 2026.
GSK was a new GM Advisory Group position in Q1 2026.
GSK made up 0.01% of GM Advisory Group's portfolio in Q1 2026, its #343 holding.
GM Advisory Group first reported a position in GSK in Q2 2023 and has held it in 10 quarters since.
GM Advisory Group's GSK position peaked at $289K in Q1 2024.
1,035 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.